Who Holds Celldex Therapeutics, Inc. (CLDX)? 253 Institutional Holders, Q2 2026
Managers with more than $100 million in US equities report their holdings on Form 13F within 45 days of each quarter end. Quarter ended 30 Jun 2026: 253 holders, $3.0 billion in total.
Largest holders
The 100 largest by value. Change in shares against Q1 2026.
| Manager | Shares | Value | Change | |
|---|---|---|---|---|
| WELLINGTON MANAGEMENT GROUP LLP | 9,543,671 | $355 million | +11% | 13F |
| BlackRock, Inc. | 7,002,530 | $261 million | +30% | 13F |
| Kynam Capital Management, LP | 5,322,908 | $198 million | -9% | 13F |
| STATE STREET CORP | 3,900,427 | $145 million | +39% | 13F |
| FMR LLC | 3,722,888 | $139 million | -1% | 13F |
| VANGUARD CAPITAL MANAGEMENT LLC | 3,464,831 | $129 million | +17% | 13F |
| Deep Track Capital, LP | 2,939,151 | $109 million | +129% | 13F |
| Logos Global Management LP | 2,100,000 | $78 million | +367% | 13F |
| GEODE CAPITAL MANAGEMENT, LLC | 2,022,226 | $75 million | +20% | 13F |
| Eversept Partners, LP | 1,785,941 | $66 million | 0% | 13F |
| GOLDMAN SACHS GROUP INC | 1,615,343 | $60 million | +63% | 13F |
| Commodore Capital LP | 1,350,000 | $50 million | -50% | 13F |
| Bellevue Group AG | 1,200,000 | $45 million | +0% | 13F |
| BAKER BROS. ADVISORS LP | 1,182,611 | $44 million | +78% | 13F |
| MILLENNIUM MANAGEMENT LLC | 1,170,787 | $44 million | -7% | 13F |
| DIMENSIONAL FUND ADVISORS LP | 1,073,985 | $40 million | +1% | 13F |
| AMERICAN CENTURY COMPANIES INC | 1,042,395 | $39 million | +22% | 13F |
| EVENTIDE ASSET MANAGEMENT, LLC | 1,037,000 | $39 million | +0% | 13F |
| NOVO HOLDINGS A/S | 1,025,000 | $38 million | -15% | 13F |
| Elmind Capital, LP | 990,000 | $37 million | +14% | 13F |
| Driehaus Capital Management LLC | 989,442 | $37 million | New | 13F |
| Fisher Asset Management, LLC | 985,677 | $37 million | -3% | 13F |
| Pictet Asset Management Holding SA | 917,408 | $34 million | -1% | 13F |
| Foresite Capital Management VI LLC | 879,713 | $33 million | +178% | 13F |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 863,536 | $32 million | +37% | 13F |
| Assenagon Asset Management S.A. | 788,696 | $29 million | +438% | 13F |
| NORTHERN TRUST CORP | 719,647 | $27 million | +25% | 13F |
| Woodline Partners LP | 700,830 | $26 million | +40% | 13F |
| Affinity Asset Advisors, LLC | 700,000 | $26 million | +40% | 13F |
| Rock Springs Capital Management LP | 699,146 | $26 million | +8% | 13F |
| TWO SIGMA INVESTMENTS, LP | 661,235 | $25 million | +383% | 13F |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 655,954 | $24 million | +20% | 13F |
| ALGERT GLOBAL LLC | 647,836 | $24 million | +201% | 13F |
| ADAR1 Capital Management, LLC | 619,542 | $23 million | +45% | 13F |
| BANK OF AMERICA CORP /DE/ | 607,195 | $23 million | -14% | 13F |
| PANAGORA ASSET MANAGEMENT INC | 572,538 | $21 million | +302% | 13F |
| Nuveen, LLC | 568,460 | $21 million | +181% | 13F |
| VANGUARD FIDUCIARY TRUST CO | 552,973 | $21 million | +29% | 13F |
| 5AM Venture Management, LLC | 497,270 | $19 million | +0% | 13F |
| FEDERATED HERMES, INC. | 492,893 | $18 million | New | 13F |
| UBS Group AG | 481,997 | $18 million | +62% | 13F |
| Candriam S.C.A. | 481,125 | $18 million | +73% | 13F |
| Ikarian Capital, LLC | 478,500 | $18 million | +4% | 13F |
| BRAIDWELL LP | 436,646 | $16 million | -68% | 13F |
| Redmile Group, LLC | 433,921 | $16 million | +66% | 13F |
| CITIGROUP INC | 404,703 | $15 million | +86% | 13F |
| Palo Alto Investors LP | 399,856 | $15 million | +35% | 13F |
| TSP Capital Management Group, LLC | 371,127 | $14 million | New | 13F |
| PFM Health Sciences, LP | 342,751 | $13 million | +5% | 13F |
| KENNEDY CAPITAL MANAGEMENT LLC | 342,328 | $13 million | -3% | 13F |
| SEGALL BRYANT & HAMILL, LLC | 336,291 | $13 million | -3% | 13F |
| Tetragon Partners GP Ltd | 290,441 | $11 million | -7% | 13F |
| SUPERSTRING CAPITAL MANAGEMENT LP | 287,583 | $11 million | +60% | 13F |
| GordonMD Global Investments LP | 279,720 | $10 million | +64% | 13F |
| SummitTX Capital, L.P. | 254,959 | $9 million | +8% | 13F |
| SPHERA FUNDS MANAGEMENT LTD. | 240,868 | $9 million | -1% | 13F |
| Bank of New York Mellon Corp | 224,176 | $8 million | +18% | 13F |
| Rosalind Advisors, Inc. | 200,000 | $7 million | -39% | 13F |
| MORGAN STANLEY | 196,974 | $7 million | -9% | 13F |
| Universal- Beteiligungs- und Servicegesellschaft mbH | 195,788 | $7 million | +179% | 13F |
| Trexquant Investment LP | 184,524 | $7 million | New | 13F |
| Mirador Capital Partners LP | 181,054 | $7 million | +2% | 13F |
| STEMPOINT CAPITAL LP | 178,412 | $7 million | -30% | 13F |
| Corient Private Wealth LP | 176,956 | $7 million | +1109% | 13F |
| DEUTSCHE BANK AG\ | 176,592 | $7 million | +23% | 13F |
| JPMORGAN CHASE & CO | 157,241 | $6 million | -5% | 13F |
| Cinctive Capital Management LP | 145,637 | $5 million | +253% | 13F |
| BOOTHBAY FUND MANAGEMENT, LLC | 140,064 | $5 million | +4% | 13F |
| FIRST TRUST ADVISORS LP | 138,682 | $5 million | +103% | 13F |
| Swiss National Bank | 135,000 | $5 million | +15% | 13F |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 134,958 | $5 million | +12% | 13F |
| MONTANOVA CAPITAL, LLC | 121,297 | $5 million | New | 13F |
| Connor, Clark & Lunn Investment Management Ltd. | 120,428 | $4 million | -35% | 13F |
| Point72 Asset Management, L.P. | 117,217 | $4 million | -96% | 13F |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 117,045 | $4 million | -4% | 13F |
| Jump Financial, LLC | 116,293 | $4 million | +1219% | 13F |
| RHUMBLINE ADVISERS | 104,963 | $4 million | +22% | 13F |
| Propel Bio Management, LLC | 103,695 | $4 million | -21% | 13F |
| Invesco Ltd. | 103,131 | $4 million | +10% | 13F |
| Russell Investments Group, Ltd. | 100,452 | $4 million | +1083% | 13F |
| Integral Health Asset Management, LLC | 100,000 | $4 million | New | 13F |
| Odyssean, LLC | 95,069 | $4 million | New | 13F |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 89,338 | $3 million | +15% | 13F |
| HighVista Strategies LLC | 86,964 | $3 million | -3% | 13F |
| AQR CAPITAL MANAGEMENT LLC | 86,893 | $3 million | +1017% | 13F |
| Seven Fleet Capital Management LP | 86,664 | $3 million | +196% | 13F |
| PDT Partners, LLC | 80,899 | $3 million | -17% | 13F |
| TD Asset Management Inc | 79,326 | $3 million | +13% | 13F |
| ALPS ADVISORS INC | 79,165 | $3 million | +46% | 13F |
| WELLS FARGO & COMPANY/MN | 78,176 | $3 million | +122% | 13F |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 77,723 | $3 million | -2% | 13F |
| ALLIANCEBERNSTEIN L.P. | 88,640 | $3 million | +35% | 13F |
| XTX Topco Ltd | 75,135 | $3 million | +522% | 13F |
| Birchview Capital, LP | 69,900 | $3 million | 0% | 13F |
| Quantinno Capital Management LP | 69,048 | $3 million | +5% | 13F |
| DAFNA Capital Management LLC | 68,518 | $3 million | +0% | 13F |
| Man Group plc | 63,504 | $2 million | New | 13F |
| Legal & General Group Plc | 59,551 | $2 million | +8% | 13F |
| Rafferty Asset Management, LLC | 56,157 | $2 million | -14% | 13F |
| Caption Management, LLC | 55,700 | $2 million | New | 13F |
Questions and answers
- How many institutions hold Celldex Therapeutics, Inc.?
- 253 managers reported Celldex Therapeutics, Inc. on Form 13F for the quarter ended 30 June 2026, against 228 the quarter before.
- Who is the largest institutional holder of Celldex Therapeutics, Inc.?
- WELLINGTON MANAGEMENT GROUP LLP, with 9,543,671 shares worth $355 million on its 13F for Q2 2026.
- How many institutions bought or sold out of Celldex Therapeutics, Inc. in Q2 2026?
- 49 managers reported a new position and 24 reported none after holding it the quarter before.
Source: SEC EDGAR, Form 13F (public domain). Counts and values as filed. Cite this page: Tamarly Intelligence, "Who holds Celldex Therapeutics, Inc., Q2 2026", https://app.tamarly.ai/holders/celldex-therapeutics, built from SEC EDGAR.
Research from public records, not investment advice. Tamarly holds no investment positions. By reading these pages you accept the Terms of Use; figures can be late or wrong, so check the linked source before relying on one. Terms and policies.